111 related articles for article (PubMed ID: 35025324)
1. From Ancient Medicine to Targeted Nanocarrier: A Sparganii Rhizoma-Derived Nanoparticle for Diagnostic Imaging and Endocrine Therapy in Cancer.
Wu YZ; Shen YK; Chen YJ; Sun J
ACS Appl Bio Mater; 2020 Apr; 3(4):2028-2039. PubMed ID: 35025324
[TBL] [Abstract][Full Text] [Related]
2. Selective estrogen receptor modulator: A novel polysaccharide from Sparganii Rhizoma induces apoptosis in breast cancer cells.
Wu YZ; Sun J; Wang YB
Carbohydr Polym; 2017 May; 163():199-207. PubMed ID: 28267497
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Fibroblast Activation in Uterine Leiomyoma by Components of
Feng Y; Zhao Y; Li Y; Peng T; Kuang Y; Shi X; Wang G; Peng F; Yu C
Front Public Health; 2021; 9():650022. PubMed ID: 33732680
[No Abstract] [Full Text] [Related]
4. Anti-cancer effects of Grailsine-Al-glycoside isolated from Rhizoma Sparganii.
Zhang JW; Wei YH
BMC Complement Altern Med; 2014 Mar; 14():82. PubMed ID: 24589031
[TBL] [Abstract][Full Text] [Related]
5. Discovery and identification of quality markers of
Xu N; Sun R; Shi YP; Han LW; Shi HY
Chin Herb Med; 2021 Jul; 13(3):389-395. PubMed ID: 36118923
[TBL] [Abstract][Full Text] [Related]
6. [Study on quality evaluation of Sparganii rhizoma by biopotency determination method].
Chen GY; Wu QN; Wang XS; Liang QL; He XX
Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2913-6. PubMed ID: 23270233
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity and linear-diarylheptanoids of herbal couple Curcumae Rhizoma-Sparganii Rhizoma and the single herbs.
Chang YL; Xu GL; Wang XP; Yan X; Xu X; Li X; Chen ZK; Ren X; Chen XQ; Zhang JH; Wang XH; Ren XY; Liu XY; Wang Y; Sun SQ; Li X; She GM
J Ethnopharmacol; 2020 Mar; 250():112465. PubMed ID: 31821851
[TBL] [Abstract][Full Text] [Related]
8. Biocatalytic cascade to polysaccharide amination.
Feng X; Hong S; Zhao H; Vuong TV; Master ER
Biotechnol Biofuels Bioprod; 2024 Feb; 17(1):34. PubMed ID: 38409122
[TBL] [Abstract][Full Text] [Related]
9. Sparganii Rhizoma: A review of traditional clinical application, processing, phytochemistry, pharmacology, and toxicity.
Jia J; Li X; Ren X; Liu X; Wang Y; Dong Y; Wang X; Sun S; Xu X; Li X; Song R; Ma J; Yu A; Fan Q; Wei J; Yan X; Wang X; She G
J Ethnopharmacol; 2021 Mar; 268():113571. PubMed ID: 33181282
[TBL] [Abstract][Full Text] [Related]
10. Ameliorative Effects of Component Chinese Medicine From
Zhang L; Xu Q; Li Y; Zhao H; Shi X; Peng F; Yu C
Front Public Health; 2021; 9():674357. PubMed ID: 34123993
[TBL] [Abstract][Full Text] [Related]
11. An integrated approach to uncover anti-tumor active materials of Curcumae Rhizoma-Sparganii Rhizoma based on spectrum-effect relationship, molecular docking, and ADME evaluation.
Liu XY; Chang YL; Wang XH; Wang Y; Ren XY; Ma JM; Yu AX; Wei J; Fan QQ; Dong Y; Song RL; Yao JL; Shan DJ; She GM
J Ethnopharmacol; 2021 Nov; 280():114439. PubMed ID: 34293455
[TBL] [Abstract][Full Text] [Related]
12. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression.
Bowers LW; Cavazos DA; Maximo IX; Brenner AJ; Hursting SD; deGraffenried LA
Breast Cancer Res; 2013; 15(4):R59. PubMed ID: 23880059
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
Tsai CL; Wu HM; Lin CY; Lin YJ; Chao A; Wang TH; Hsueh S; Lai CH; Wang HS
PLoS One; 2013; 8(9):e72999. PubMed ID: 24039841
[TBL] [Abstract][Full Text] [Related]
14.
Wei J; Wang X; Dong Y; Zhong X; Ren X; Song R; Ma J; Yu A; Fan Q; Yao J; Shan D; Lv F; Zheng Y; Deng Q; Li X; He Y; Fan S; Zhao C; Wang X; Yuan R; She G
Front Pharmacol; 2022; 13():1027687. PubMed ID: 36561345
[No Abstract] [Full Text] [Related]
15. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
[TBL] [Abstract][Full Text] [Related]
16. Indocyanine Green-Loaded Silver Nanoparticle@Polyaniline Core/Shell Theranostic Nanocomposites for Photoacoustic/Near-Infrared Fluorescence Imaging-Guided and Single-Light-Triggered Photothermal and Photodynamic Therapy.
Tan X; Wang J; Pang X; Liu L; Sun Q; You Q; Tan F; Li N
ACS Appl Mater Interfaces; 2016 Dec; 8(51):34991-35003. PubMed ID: 27957854
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells.
Zavatti M; Guida M; Maraldi T; Beretti F; Bertoni L; La Sala GB; De Pol A
Life Sci; 2016 Nov; 164():15-22. PubMed ID: 27629493
[TBL] [Abstract][Full Text] [Related]
18. Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
Jacquemetton J; Kassem L; Poulard C; Dahmani A; De Plater L; Montaudon E; Sourd L; Morisset L; El Botty R; Chateau-Joubert S; Vacher S; Bièche I; Treilleux I; Trédan O; Marangoni E; Le Romancer M
Breast Cancer Res; 2021 May; 23(1):57. PubMed ID: 34020697
[TBL] [Abstract][Full Text] [Related]
19. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
20. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
